Actos Hip Fracture Warnings Should Be Updated Due to Severe Risk: Study
The warning label for the popular diabetes drug Actos, as well as the already heavily restricted drug Avandia, should be updated to include stronger warnings about a potential increased risk of hip...
View ArticleDiscovery Procedures Established in Actos Bladder Cancer MDL
The judge presiding over the federal Actos litigation has issued an order establishing the discovery protocol for product liability lawsuits filed by individuals who developed bladder cancer after...
View ArticleTestimony of Actos Plaintiffs With Severe Health Problems To Be Preserved
As an increasing number of individuals who are suffering bladder cancer from Actos grow sicker, a federal judge has issued an order establishing how testimony may be preserved for those who may not...
View ArticleAmid Actos Suits and Declined Sales, Takeda Pushes New Diabetes Drug
As sales of the brand-name version of the diabetes drug Actos continue fall amid mounting injury lawsuits and recent generic competition, Takeda Pharmaceuticals has launched a trio of new drugs meant...
View ArticleCourt Appoints Actos Lawyer as Liaison Counsel for Pro Se in MDL
The judge presiding over the federal Actos litigation, involving product liability lawsuits brought by individuals who developed bladder cancer after taking the type 2 diabetes drug, has designated an...
View ArticleTrial for Actos Cancer Lawsuit Begins This Week
The first of several thousand Actos lawsuits filed on behalf of former users who developed bladder cancer after using the popular diabetes drug is set for trial to begin this week in California state...
View ArticleActos Bellwether Trials in MDL to Begin January 2014
As the first Actos trial in the country is being presented to a California state court jury on behalf of a former users of the diabetes drug diagnosed with bladder cancer, the U.S. District Judge...
View ArticleActos Bladder Cancer Risk Discussed in Takeda Email in 2005: Trial
E-mails dating back to 2005 appear to show that Takeda Pharmaceuticals executives not only knew there was a potential increased risk of bladder cancer with Actos, but suggest that the drug maker was...
View ArticleNew J&J Medication, Invokana, Hopes To Break Diabetes Drug Curse
Johnson & Johnson has high hopes that its recently approved diabetes drug, Invokana, will break the trend of problems that have surfaced in recent years with many newer diabetes medications,...
View ArticleSecond Trial in Actos Bladder Cancer MDL Scheduled for April 2014
As trial continues in California state court for the first Actos bladder cancer lawsuit to be presented to a jury, the U.S. District Judge presiding over the federal litigation has scheduled “hard and...
View ArticleJury Deliberating in First Actos Bladder Cancer Case
A California state court jury is continuing deliberations following the first Actos trial in the country, which alleges that side effects of the popular type 2 diabetes drug caused a user to develop...
View ArticleFirst Actos Lawsuit Results in $6.5M Jury Award Over Bladder Cancer
A California man who claims that he developed bladder cancer from Actos has been awarded $6.5 million by a California jury, which found that Takeda Pharmaceuticals failed to adequately warn about the...
View ArticleActos Bladder Cancer Damage Award of $6.5M Overruled By Judge
The California state court judge who presided over the first Actos bladder cancer trial in the country, has issued a post-trial ruling rejecting key expert witness testimony, which has resulted in a...
View ArticleActos Litigation in Federal Court Now Includes More Than 1,500 Cases
More than 1,500 Actos bladder cancer lawsuits have been filed against Takeda Pharmaceuticals in the federal court system, with the first cases expected to go to trial early next year. Actos...
View ArticleActos Lawsuit
Side effects of the popular diabetes drug Actos may increase the risk of bladder cancer. Health regulators in several foreign countries have suspended sales of the drug and the FDA required new...
View ArticleActos Removed from Market in India Amid Bladder Cancer Risk
Following mounting concerns worldwide over the risk of heart failure and bladder cancer from Actos, India became the latest country to ban the popular diabetes drug last month. The Indian Ministry of...
View ArticleActos Bladder Cancer Lawsuit Goes to Trial Before Maryland Jury
Takeda Pharmaceuticals faces it’s second trial for an Actos lawsuit involving allegations that the drug maker knew it’s blockbuster diabetes drug increased the risk of bladder cancer, but placed the...
View ArticleSulphonylurea Diabetes Drugs May Increase Heart Attack Risk: Study
New research appears to confirm the heart risks associated with a long-established class of diabetes drugs known as sulphonylureas, which includes Diabeta, Glynase and Micronase. The study was...
View ArticleJury Awards $1.7M for Cancer from Actos, But Defense Verdict Entered
In the second trial out of more than 3,000 Actos lawsuits pending nationwide, a Maryland jury found that Takeda Pharmaceutical’s failed to adequately warn physicians about the risk of bladder cancer...
View ArticleActos Wrongful Death Claims Added as Plaintiffs Die of Bladder Cancer
As the Actos litigation continues to move forward in state and federal courts throughout the country, alleging that side effects of the popular diabetes drug caused plaintiffs to develop bladder...
View Article
